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Background: The polycystic ovary syndrome (PCOS) affects approximately 6-10% of women of reproductive age
and is characterized by chronic anovulation and hyperandrogenism. However, a comprehensive understanding of
the mechanisms that dictate androgen overproduction is lacking, which may account for inconsistencies between
measures of androgen excess and clinical presentation in individual cases.
Methods: A rat model of PCOS was established by injecting dehydroepiandrosterone sulfoconjugate (DHEAS) into
pregnant females. Rats were administered with DHEAS (60 mg/kg/d) subcutaneously (s.c.) for all 20 days of
pregnancy (Group A), or for the first 10 days (Group B), or from day 11 to day 20 (Group C). Controls were
administered with injection oil (0.2 ml/day) s.c. throughout pregnancy (Group D). The litter rate, abortion rate, and
offspring survival rate in each group were recorded. Serum androgen and estrogen were measured and the
morphological features of the ovaries were examined by light and electron microscopy in the offspring of each
group.
Results: We found that rats injected with DHEAS throughout pregnancy (group A) lost fertility. Rats injected with
DHEAS during early pregnancy (group B) exhibited more serious aberrations in fertility than both Group C, in which
rats were injected with DHEAS during late pregnancy (P< 0.05), and Group D (controls). There was a statistical
difference of ovarian weight among female offspring in Group B, C and D (P< 0.01). By light and electron
microscopy, a significant morphological difference among the female offspring in the three groups was observed.
Conclusions: Our results indicate that androgen excess during pregnancy can decrease rat fertility. Excess androgen
at the early stage of pregnancy causes high reproductive toxicity, leading to abnormality of ovarian morphology
and functions in female offspring.
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Polycystic ovary syndrome (PCOS) is the most common
endocrine disorder in premenopausal women [1]. In
different ethic populations, the prevalence of PCOS is
about 5-10% [2,3]. In clinic, PCOS patients are usually
diagnosed by a distinguishing polycystic appearance of
the ovary and a wide range of biochemical markers
including elevated serum androgens, insulin, luteinizing
hormone (LH), and decreased insulin sensitivity [4]. Both* Correspondence: Xuefengx@gmail.com
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reproduction in any medium, provided the orhealthy women and women with abnormal cycles and
hyperandroenism could develop PCOS, however, over-
weight or obese girls are much more predisposed to
PCOS [4,5].
Currently, the etiology of PCOS remains largely
unknown. It is believed that both genetic factors and
gestational environment contribute to its origin and
development, and prenatal androgen exposure is considered
one of the important factors in the early origins of PCOS
[1,6,7]. It has been found that adrenal androgen excess pre-
sents in approximately 25-60% of women with PCOS, in
which dehydroepiandrosterone (DHEA), dehydroepiandros-
terone sulfoconjugate (DHEAS), and androstenedione aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Epidemiological studies reported that girls at high risk for
PCOS may have early androgen excess [10,11]. Experiments
with nonhuman primate model for PCOS demon-
strated that prenatally androgenized female monkeys
had enhanced basal and adrenocorticotropic hormone
(ACTH)-stimulated adrenal androgen levels [8,12-15].
In sheep, exposure of the pregnant ewe to large doses
of testosterone causes increased LH secretion and
abnormal ovarian cycles in female offspring [16-18].
Recently, studies proved that in uetro androgen expos-
ure in adult female rats could also develop the PCOS
related metabolic syndrome [19,20]. Therefore, a
strong association of PCOS development and prenatal
androgen excess were well supported by literature.
The mechanisms for PCOS development caused by
the prenatal androgenization are still under inves-
tigation. Human studies suggest continuing actions of
hyperandrogenemia are important for sustaining the
abnormal hypothalamic sensitivity to feedback inhib-
ition by ovarian steroids [21]. In cultured human theca
cells from PCOS patients, 20 times more androstene-
dione was produced than normal cells [22,23]. In rat
models, prenatal androgenization leads to higher pro-
gesterone receptor mRNA expression and more LH
secretion, prolonged anogenital distance and fewer nip-
ple numbers, irregular or prolonged estrous cycles [20].
Therefore, a global change in the reproductive system and
ovarian functions in PCOS patients is suggested. As animal
models are useful in understanding the pathogenesis of
PCOS, it is important to examine the histopathological
alterations in ovaries from prenatal androgenized animal
models [24].
In current study, we established a rat model of PCOS
by injecting androgen into pregnant females. The weight,
morphology, and functions of the ovaries of female
offspring in different treated groups were compared, and
the detailed histopathological alterations in ovaries of
prenatal androgenized female rats were examined. The
major goal of this study is to determine the impact of
prenatal androgenization on ovary development in fe-
male offspring, which is lacked in most reported litera-
tures, and to provide new insights into the mechanisms
of prenatal androgenization and PCOS development.
Methods
Animals and drugs
The study protocol was approved by the institutional
Animal Care and Use Committee of Guangzhou Medical
University. Rats were purchased from and housed in the
Animal Center of Guangzhou Medical University.
DHEAS and injection oil were purchased from Hubei
Fangtong Pharmaceutical Co., Ltd. The rats were main-
tained on a controlled light cycle of 14:10 h (light/dark)at 25°C with water and food ad libitum. All animal pro-
cedures were reviewed and approved by the Guangzhou
Medical University before implementation.Administration of DHEAS
Rats were administered with DHEAS between 8:30 and
10:30 a.m. DHEAS (60 mg/kg/d) was dissolved in 0.2 ml
injection oil and injected subcutaneously (s.c.) in the
inner thighs of rats. The first day of pregnancy was
defined by first sight of a vaginal plug. Thirty-two female
SD rats (16-week-old, weighing 180–200 g) were ran-
domly subdivided into 4 groups (Group A-D) for differ-
ent treatments. Group A: rats were injected with
DHEAS (60 mg/kg/d) during the whole pregnancy (day
1 to day 20). Group B: rats were injected with DHEAS
(60 mg/kg/d) during the first half pregnancy (day 1 to
day 10). Group C: rats were injected with DHEAS
(60 mg/kg/d) during the second half pregnancy (day 11
to day 20). Group D (control): rats were injected with oil
only (day 1 to day 20). The litter rate, abortion rate, and
offspring survival rate were recorded. If abortion oc-
curred, the rat was impregnated again after 1–2 weeks.
The female offspring of each group were Group A’, B’, C’,
and D’ accordingly, and their serum androgen and estro-
gen were measured and the morphological features of
the ovaries were examined by light and electron micros-
copy. Experiments were repeated for at least 3 times,
average results or representative figures were analyzed.Determination of estrus cycle, pregnancy, and rate
abortion
The estrus cycle was determined by vaginal exfoliative
cytology and the ovulation was observed. The estrus
cycle of rats is approximately 4–5 days, including proes-
trus, estrus, metestrus, and anestrus. The pregnancy
period of rats is 21 days on average from first sight of
the vaginal plus, and ranges from 19–23 days. To meas-
ure vaginal exfoliation, a cotton swab soaked in saline
was inserted into the vagina, rotated, and the adherent
mucous tissue smeared on slides for hematoxylin and
eosin (HE) staining. The morphologic features of vaginal
exfoliative cells were examined by light microscopy.
Early abortion, in which prenatal rats were not formed,
was judged by weighing the dames, and by examining
maternal bodies to see if abdomens were enlarged and if
breasts were appropriately developed. No increase in
body weight or reduced body weight, absence of abdom-
inal enlargement, and lack of breast development were
taken as signs of early abortion. Late abortion was mea-
sured by dead bodies in the cage. If the external genitalia
of the maternal body or cushions were stained with
blood, the offspring may have been eaten, which was also
considered to be abortion. Offspring survival rates were
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the number at birth in each group.Measurement of serum sex hormones
The serum levels of sex hormone were determined by
microparticle chemiluminescent immunoassay kits (Beck-
man Corporation of America) according to the manufac-
turer’s instructions. Intraday and interday coefficients of
variation were below 10%. Three independent experiments
were performed and the results were compared by inde-
pendent sample t-test using SPSS 13.0 (SPSS Inc. USA). A
two-sided P value of 0.05 was considered statistically
significant.Tissue sample collection and histochemistry
The offspring were sacrificed on the seventh day of the
10th week (equivalent to adolescence), and serum sam-
ples and ovaries were collected. Blood samples were col-
lected by cardiac puncture, centrifuged at 2000 rpm,
and plasma was collected and stored at −20°C for hor-
mone analysis. After taking blood samples, both ovaries
were quickly removed, cleared up and weighed. The
visible morphologic changes of both ovaries including
color and texture were recorded. After that, one ovary
was quickly rinsed in phosphate buffered saline (PBS),
fixed in 2.5% glutaraldehyde solution, and stored at 4°C
for further processing and transmission electron micros-
copy, while the other ovary was fixed in 10% formalin
solution and stored at 4°C for HE staining and light
microscopic examination. Partly wax-enveloped ovarian
tissues were stained with HE and the growth of follicles
observed by microscopy and compared between off-
spring groups. The contralateral ovaries were prepared
for transmission electron microscopy, and changes in
their cellular and subcellular structures were analyzed
and compared.Figure 1 Histological examination of normal ovaries. A and B.
light microscopy photographs of ovaries from rat offspring in the
controls (HE × 200).Results
Litter rate, abortion rate, and offspring survival rate
During the first round of androgen treatment, pregnant
rats in Groups A, B, and C had abortion rates of 100%,
while the rate is 0% in Group D (controls). After abor-
tion, the rats were kept in the same cage. No pregnancy
occurred in Group A after 10 estrus cycles. Exfoliative
cytoscopy of vagina showed that typical periodic changes
in Group A rats were absent, while Groups B and C were
able to become pregnant and carry litters to term. The
offspring survival rate was 65% in Group B, 70.97% in
Group C, and 71.43% in Group D. There was a statistical
difference in survival rate between Group B and C
(P< 0.05), and between Group B and D (P< 0.05) by in-
dependent sample t-test. No statistical difference in sur-
vival rate was found between Group C and D (P> 0.05).Anatomic changes in offspring ovaries
The ovaries of Group B’ and C’ were slightly larger than
those of Group D’. Some of ovaries of Group B’ and C’
were slightly red on the surface and no obvious vesicae
were observed. The others were pale on the surface, and
many vesicae were observed, especially in Group C’. The
ovaries of Group D’ were uniformly red in color. The
ovarian weight was 0.029 ± 0.007 g in Group B’,
0.030 ± 0.006 g in Group C’, and 0.026 ± 0.007 g in Group
D’. There was a statistical difference between Group D’
and the combined Group B’ and C’ (P< 0.05), but no sig-
nificant difference between Groups B’ and C’(P> 0.05).
Observation of ovaries in neonatal rats by light
microscopy
The corpora lutea and follicles at different developmen-
tal stages were examined in ovaries by light microscopy.
Multiple layers of granular cells were observed in off-
spring in Group D’ (Figure 1), while the number of
granular cell layers was significantly lower in offspring in
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theca cell layers was greater than in offspring in Groups
B’ and C (Figure 2). In Groups B’ and C’, primary follicles
and primordial follicles increased in diameter and con-
tained numerous cystic preantral follicles and cystic folli-
cles (Figure 2B). Oocytes and corona radiata were absent
and the follicles were surrounded by hyperplastic lutei-
nized cells of the follicular inner membrane. Hyperplasia
of mesenchymal cells in the ovary cortex was also obvi-
ous (Figure 2).
Observation of ovaries in neonatal rats by electron
microscopy
Mitochondria, microtubules, rough and smooth endo-
plasmic reticulum, and some lipid drops were observed
in the control group by electron microscopy (Figure 3).
Organelles involved in the synthesis of proteins were
abundant in the granular cells and follicular cells of
Groups B’ and C’; the number of mitochondria was
higher than controls but the mitochondrial crista wereFigure 2 Representative histopathological alterations in ovaries
of prenatal androgenized female rats. A. PCOS resembling
changes with decreased granular cells in ovaries of rat offspring in
the Group B and C (HE × 100). B. Preantral follicles and cystic follicles
in ovaries of rat offspring in the Group B and C (HE× 200).
Figure 3 Electron micrographs of ovaries from rat offspring in
different groups. A. ovaries from rat offspring in the controls
(TME × 12000). B. ovaries from rat offspring in the Group B and C.
Arrows indicated the granular cells (TME× 12000). C. ovarian granular
cells of rat offspring in the Group B and C (TME× 12000).blurred and faded (Figure 3B). Some mitochondria were
spherical and pyknotic, swollen or even ruptured,
replaced by lipid drops and vesicae. Ribosomes were
abundant but smooth endoplasmic reticulum was not.
Enlarged nucleoli, irregular nucleoli, reduced nucleo-
plasm, shrunken nuclear membranes, and local swelling
were observed (Figure 3B). Some oocytes had uneven
cytoplasm in which mitochondria were swollen and
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reticulum was expanded, degranulated, disorganized, and
even showed signs of rupture. Golgi bodies were also
swollen and their boundaries blurred. Few polyribosomes
were observed, local cytoplasmic lamellar structure was
absent (Figure 3B). Numerous lipid droplets and vacuoles
were observed in granular cells and in the cytoplasm of
cells of the follicular membrane (Figure 3C).Serum androgen and estrogen levels
The serum concentrations of follicle stimulating hor-
mone (FSH) and LH were below 0.5 IU/L, and prolactin
(PRL) were below 0.5 ng/mL in Groups B', C', and D'
(data not shown). The serum testosterone level was sig-
nificantly higher in the treated groups (B' and C') than in
the control group (P< 0.01). In contrast to serum testos-
terone, serum estradiol (E2) was lower in Group C' than
Group B' (P< 0.01). Group B' had the highest levels of
serum estradiol, and group C’ had the highest levels of
serum testosterone in the three groups (Table 1).Discussion
In this study, we demonstrated that elevated androgen
levels during pregnancy significantly disrupted pregnancy
and leaded to a PCOS-like syndrome in the female off-
spring. No pregnancies occurred in rats receiving daily
injections of androgens throughout pregnancy, even after
10 estrus cycles. Exfoliative cytoscopy of their vagina
showed no typical periodic changes associated with es-
trus, while rats treated with androgens during the first
and second halves of pregnancy were able to undergo
pregnancy after an initial period of infertility. Therefore,
consisting with earlier reports [19,20,25], our data
showed that high androgen levels during pregnancy had
significant negative impacts on fertilization and could
lead to permanent histopathological alterations in ovaries
of female offspring (Table1, Figure 1, 2, 3).
Our results demonstrated that the offspring survival
rate of rats treated with androgens during the first halvesTable 1 Comparison of serum hormone levels among
Group B’, C’, and D’a
Group N Testosterone (ng/ml) Estradiol (pg/ml)
Group B' 35 3.84 ± 0.63b 50.11 ± 7.98d
Group C' 39 9.07 ± 1.42c 30.67 ± 6.89ef
Group D' 42 2.59 ± 0.42 39.56 ± 3.75
a: Group B’: female offspring of rats injected with DHEAS (60 mg/kg/d) during
the first half pregnancy. Group C’: female offspring of rats injected with DHEAS
(60 mg/kg/d) during the second half pregnancy. Group D’ (control): female
offspring of rats injected with oil only.
b: P< 0.01 compared to Group D'.
c: P< 0.01 compared to Group B' or Group D'.
d: P< 0.01 compared to Group D'.
e: P< 0.05 compared to Group D'.
f: P< 0.01 compared to Group B'.of pregnancy was lower than that of rats treated with
androgens during the second halves of pregnancy or
controls (P< 0.05). Our data was consist with studies of
Dumesic et al., who reported that rhesus monkeys
exposed to high androgen during the first trimester
showed deficient oocyte development compared to
mothers treated during the third trimester [15]. It has
been found that oocytes collected from rhesus monkeys
with early prenatal androgenization were normally ferti-
lized but abnormal development occurred after 8 cell
phases compared to the control group [26], partially due
to prematurity and aging of oocytes at ovulation and cor-
responding high spontaneous abortion rate. The reason
for this might come from hormone disruption by andro-
gen in the early stage of embryo development. It was
known that high androgen levels during the first trimes-
ter disrupted fetal gonad differentiation, pancreas forma-
tion, and neuroendocrine development. During the first
half of pregnancy, androgen administration increased the
secretion of Gonadotropin-releasing hormone (GnRH) in
the fetuses, which might also elevate maternal GnRH
through the umbilical arteriovenous circulation and dis-
rupt the whole maternal hypothalamus-pituitary-gonadal
axis. Therefore, mothers exposed to high androgen dur-
ing the first trimester might suffer more adverse effects
on fertility than those exposed during the second and
third trimesters.
In this experiment, there were significant differences in
ovary weights and morphology between controls and rats
treated with androgens during the first and second
halves of pregnancy. Significant morphologic differences
between the androgen-treated groups and the control
group were observed by light microscopy while changes
in organelle structures were observed by electron mi-
croscopy (Figure 1, 2, 3). In addition, excessive theca
cells caused an elevation in serum sex hormones
(Table 1). Since organ morphology is always linked with
its function, the PCOS resembling histopathological
alterations in ovaries of prenatal androgenized female
rats suggested that androgen affects the ovary develop-
ment first and consequent functions later. Because the
aggregation of follicles and the morphologic changes are
important characteristic in PCOS develop, our observa-
tion supported that these morphologic changes might re-
sult from androgen excess.
High androgen during early pregnancy, similar to con-
genital adrenal hyperplasia, is characterized by increased
secretion of LH, which causes secondary ovarian hyper-
androgenism. It is believed that prenatal exposure to
high androgen activates the expression of androgen re-
ceptor genes in the preoptic area of the fetal hypothal-
amus and inhibits the estrogen-induced expression of
progesterone receptor genes or even causes permanent
impairment in receptor expression. Thus, secretion
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GnRH pulse generator is characterized by frequent se-
cretion but fails at a secretion higher frequency when the
E2 peaks. Previous studies have observed metabolic dis-
turbances in adult offspring. Newborn rats prenatally
exposed to high androgen during the third trimester
developed hyperandrogenism but no obvious metabolic
syndrome as evidenced by normal body weights and the
oral glucose tolerance test (OGTT). The serum androgen
concentration in Group C' was significantly higher than
the other groups (Table 1). In addition, organelles
involved in the synthesis of proteins (rough ER and
Golgi) significantly increased but their morphologic
structures were impaired (Figure 3), which might be
related to the imbalance in hormone synthesis.
Abnormal metabolism in women may be unrelated to
hyperandrogenism following clinical development of PCOS;
rather, it reflects an ovarian structural abnormality that
causes dysfunction of the hypothalamus-pituitary-growth
axis or pancreatic islands, leading to both abnormal metab-
olism and hyperandrogenism. Since functions are based on
structures, and ovarian structural abnormality leads to dys-
function, further research is required to determine the
details in PCOS development and to improve the symptom-
atic treatment for this disease.Conclusions
In this study, our data supported that androgen excess
severely impact female rat fertility. Using a rat model of
PCOS by injecting DHEAS into pregnant females during
different stages, it was found that rats injected with
DHEAS throughout pregnancy completely lost fertility,
and rats treated during early pregnancy exhibited more
serious aberrations in fertility than rats treated during
late pregnancy compared to controls. Besides elevated
androgen levels during pregnancy, there were significant
increases of ovary weights in offspring of rats treated
with DHEAS. The female offspring of androgen-treated
rats also exhibited significant morphologic differences
and organelle structure changes in ovaries. These PCOS
resembling histopathological alterations in ovaries of
prenatal androgenized female rats suggested that andro-
gen affects both ovary development and its function.
Therefore, our study indicated excess androgen during
pregnancy, especially at the early stage, may cause high
reproductive toxicity and abnormal morphology and
functions of ovaries in female offspring.Abbreviations
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